From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board.
Molecular tumor boards successfully matched patients with personalized therapies and achieved measurable clinical benefit in real-world practice.
A single-center molecular tumor board (MTB) successfully translated genomic sequencing recommendations into matched therapy decisions with measurable clinical benefit for a meaningful subset of patients. Real-world MTB implementation data quantifies the actual impact of precision oncology programs on patient outcomes.
What the study was
- Study design
- single_center_retrospective_cohort
- Category
- precision_oncology
- Maturity
- Validated
Why it surfaced
Real-world MTB outcome data directly addressing the implementation gap in precision oncology. Relevant to precision oncology watchlist. Quantifies the actual impact of genomics-guided decision-making, a key metric for justifying MTB investments.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.